Johnson & Johnson Message Board

Search
Current Board
All Boards
Advanced Search
  • Subject Message Body
  • Topics Only Topics And Messages
  • redistributewealth redistributewealth • Jan 24, 2006 12:58 PM Flag

    Good reason for Pharm Sales decline..

    in last quarter of 2005. Major reorganization across all sales forces. Consolidation of sales forces, redeployment of sales reps. Over 500 Representatives wer let go. New Regional Directors, new geographies. This is the second time in two years that this has been done.

    This leads to total disruption of the sales effort. Less time with MD's. Spotty coverage as Reps wonder if they will have a job.

    Add this disruption to the loss of patent protection for Duragesic and Ultracet and I'm surprised that sales didn't suffer even more.

    They will bounce back.

    Sort:  Newest  |  Oldest  |  Most Replied Expand all replies
    • pcka2000 pcka2000 • Jan 24, 2006 1:03 PM Flag

      Reps are meeting their new managers & region managers as we speak. Some will give pep talks, but you hit the nail on the head, that new managers will disrupt the day to day facetime with Drs. that is vital for reps.

      Anyone ever heard of a T to T salesrep?

      • 1 Reply to pcka2000
      • quickswinger quickswinger • Jan 24, 2006 1:19 PM Flag

        A very close relative who "was" a pharmaceutical sector sales rep told me the reason(s) she has left. It was having three new, different district managers in 5 years, each one knowing less and less about the product(s), managing people and maintaining customer relationships for important accounts. Many of the outstanding sales reps on the pharm side are going to Genentech and Amgen!

 
JNJ
88.590.58(+0.66%)May 21 4:03 PMEDT